Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

3Q25 update

Macquarie Group
3:27pm
February 11, 2025
MQG’s 3Q25 update disclosed that NPAT for the first nine months (FY25 YTD) was broadly in-line with the pcp. We note MQG’s short-term outlook commentary has not changed from its last update, but the market before today was factoring in 8% FY25 NPAT growth. This implies the company needs a relatively strong Q4 to get near market expectations. We lower our MQG FY25F EPS by 6%, with nominal changes to our future year forecasts. Our PT (~A$218) is largely unchanged with our earnings changes offset by a valuation roll-forward. MQG is a quality franchise, but we think the recent strength in its share price is arguably unjustified, and we see the stock as fair value trading on ~23x FY25F earnings. We maintain a HOLD rating.

Hitting positive cashflow

Clever Culture Systems
3:27pm
February 11, 2025
Clever Culture Systems (CC5) has achieved cash flow break-even for operating activities in 2Q25 in line with previous guidance. Further to this, management has guided to the next two quarters being operating cashflow positive. CC5’s strategy is to target large pharmaceutical companies and build on the success so far with AstraZeneca and Bristol Myers. The current installed base is 22 units. Key catalysts include announcements around expansion of additional orders within the customer base and orders from new customers.

International Spotlight

McDonald's Corp
3:27pm
February 11, 2025
McDonald’s Corporation (MCD.NYS) is a global QSR (Quick Service Restaurant) business known for signature menu items such as the Big Mac, Quarter Pounder, Chicken McNuggets, and Fries. The Golden Arches logo is one of the most instantly recognisable symbols of American consumer culture in the world.

Sticker shock offers an opportunity

Car Group
3:27pm
February 10, 2025
CAR 1H25 result was resilient, with pro forma revenue growth of 9-30% across its key markets. However, it was the slight miss vs consensus at EBITDA and the deferral in putting through a price rise in the US business that saw the stock trade lower on the day, in our view. We make minor changes to our FY25-FY27F EBITDA (-1%/-+1%) on the result and guidance update. Our price target increases to A$41.40 on the above changes, an uplift to our longer-term margin assumptions and a DCF valuation roll-forward. Given ~10% TSR upside to our price target, we move to an Add recommendation.

1H beat- looks like a growth stock . . . but it’s not

Ansell
3:27pm
February 10, 2025
1H was better than expected, with strong, double-digit top and bottom line growth, but was mainly supported by acquisition gains, cost outs and one off items. Industrial sales and margins both improved on new product introductions and higher pricing, while Healthcare jumped on normalistion from channel inventory destocking and slowed production. While stocking/restocking appear “neutral” and guidance upgraded c4% at the mid-point, we remain cautious, given Healthcare’s easy gains are now limited, KBU is entering a transition period with risk of sales leakage and customer disruptions, and price increases and cost outs need to offset higher input costs and tariffs. FY25-27 EPS increases 5%, with our DCF/SOTP PT increasing to A$33.38. Hold.

1H25 Earnings: Sales perks

JB Hi-Fi
3:27pm
February 10, 2025
JBH has produced another solid result for the first half, and was ahead of consensus expectations. Sales momentum accelerated in the 2Q driven by demand for tech and consumer electronic products, and has continued into the start of the 2H. Margins were managed better than we expected given the highly promotional and competitive environment, and ongoing cost pressures. We have increased our revenue forecast as a result of strong sales momentum, which has flowed through to 3.5%/4% increase in NPAT in FY25/FY26. We have increased our TP to $92 from $87, but see the current valuation of ~23x FY26 P/E as too expensive, given its 10 year average is ~14x. We retain our HOLD recommendation. With this note, lead coverage of JB Hi-Fi passes to Emily Porter.

Strategic review is key

MedAdvisor
3:27pm
February 10, 2025
Last November, MDR announced a strategic review to help restore value to the business which has seen the market capitalisation fall over 65% since June 2024. The outcome of the review is expected to be announced in 3Q25. The 2Q25 cashflow reported lower revenue and margins than the previous corresponding period. Reflecting the lower than expected US flu vaccination rates. Management has guided to a positive EBITDA for FY25 (consensus A$2.0m). The consensus mean target price is A$0.25.

Still undercooked but getting there

Domino's Pizza
3:27pm
February 7, 2025
DMP’s now regular pre-reporting trading update was better than feared with underlying PBT in line with consensus and no major change/reset of the business announced which was widely expected. New management have so far identified A$34.1m of annualised EBIT savings for the DMP network with more to come. Given the review of the cost base is continuing, DMP has yet to determine both the size of the total savings pool and how it plans to balance how much of the savings will flow to its franchise network (to lift unit economics) vs its own bottom line. Management indicated on the conference call that in the near-term, a greater weighting of savings would likely be reinvested in the network to lift unit economics and reignite organic growth. DMP is making positive steps in the right direction, in our view. However, the key for us to turn positive is a clearer picture on what future organic top line growth will look like going forward. HOLD maintained. As part of the trading update, DMP announced A$34.1m of annualised savings with more to come. Part of these savings (A$15.5m EBIT) is the closure of 205 loss-making stores occurring in the 4Q25. 172 (58 Franchise and 114 Corporate) of those store closures will be in Japan. DMP will incur a one-off impact of A$97.2m in FY25 for these closures (A$37.4m cash impact). Management said in the call that it believes the store network has now been right-sized for future growth and doesn’t expect any future store closures. DMP has also identified A$18.6m of annualised savings associated with simplifying the network and the cost base and identifying opportunities to buy better and spend better in areas including food, packaging, and technology. Given the review of the cost base is continuing, DMP has yet to determine both the size of the total savings pool and how it plans to balance how much of the savings will flow to its franchise network (to lift unit economics) vs its own bottom line. At the FY24 result, on our estimates, DMP needed to lift average sales per store (referring to its franchise partner dashboard reported at FY24) by ~10% to achieve the desired 3 year payback. This would’ve taken ~3 years to achieve. We think the right move is for any cost savings to be reinvested in the franchise network so that the 3 year payback period is achieved sooner rather than later. DMP plans to provide a more detail update on its turnaround strategy at an Investor Day in 2H25.

International Spotlight

Pfizer Inc.
3:27pm
February 7, 2025
Pfizer is a research based pharmaceutical company that focuses on drug discovery for human diseases. It has a global portfolio including medicines and vaccines, as well as many other health care products. Its top 10 medicines and vaccines include: Comirnaty, Paxlovid, Eliquis, Prevnar, Ibrance, Vyndaqel, Xeljanz, Xtandi, Enbrel and Inlyta. The company collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. It has key franchises in cardiovascular, infectious diseases, inflammatory conditions and vaccines.

Expanding its pool of Brown Label ATM customers

Findi
3:27pm
February 7, 2025
FND has announced a new Brown Label ATM (BLA) agreement with Union Bank of India (UBI). The contract is for 7+ years and will deliver A$75m-A$80m of total revenue and A$33m-A$38m of EBITDA over the contract life. The deal is obviously a positive, in our view, noting it both diversifies FND’s BLA customer base, whilst also being strongly value accretive. We upgrade our FND FY25F/FY26F/FY27F EPS by >10% (off low bases) on both incorporation of the UBI deal into our numbers, and some tweaking of our broader earnings forecasts. Our PT is set at A$7.68 (previously A$7.17). FND management appear to be executing well on the company’s overall build out, and with +50% upside to our blended valuation (A$7.68) we maintain our ADD call.

News & Insights

Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more